Cardio vascular | September 18, 2024
Streamlining familial hypercholesterolemia testing: How Sahlgrenska University Hospital laboratory optimized workflow with Devyser FH
Find out more
All articles
Devyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Meeting Modern Demands: Overcoming Thalassemia Testing Challenges with NGS
One-size-fits-all: Addressing hemoglobinopathy using NGS
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Streamlining Thalassemia Genetic Testing with NGS: Insights from Cyprus
Devyser announces expanded commercial agreement with Thermo Fisher Scientific for post-transplant monitoring NGS products
Devyser launches updated Y-Chromosomal microdeletion test
Devyser wins all-time high tender for up to 75 MSEK
Devyser wins tender for oncology NGS solutions in Italy
